Wolverine Trading’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $864K | Buy |
6,700
+3,100
| +86% | +$372K | ﹤0.01% | 3057 |
|
|
2025
Q2 | $385K | Buy |
+3,600
| New | +$391K | ﹤0.01% | 3211 |
|
|
2025
Q1 | – | Sell |
-2,800
| Closed | -$344K | – | 5287 |
|
|
2024
Q4 | $344K | Sell |
2,800
-1,100
| -28% | -$130K | ﹤0.01% | 3864 |
|
|
2024
Q3 | $433K | Sell |
3,900
-5,200
| -57% | -$570K | ﹤0.01% | 3205 |
|
|
2024
Q2 | $971K | Buy |
9,100
+6,100
| +203% | +$671K | ﹤0.01% | 2209 |
|
|
2024
Q1 | $361K | Buy |
3,000
+400
| +15% | +$49K | ﹤0.01% | 3163 |
|
|
2023
Q4 | $320K | Sell |
2,600
-1,600
| -38% | -$200K | ﹤0.01% | 3393 |
|
|
2023
Q3 | $544K | Buy |
4,200
+2,000
| +91% | +$266K | ﹤0.01% | 2692 |
|
|
2023
Q2 | $272K | Sell |
2,200
-1,300
| -37% | -$175K | ﹤0.01% | 3208 |
|
|
2023
Q1 | $507K | Buy |
3,500
+600
| +21% | +$88.8K | ﹤0.01% | 2487 |
|
|
2022
Q4 | $462K | Buy |
2,900
+1,100
| +61% | +$161K | ﹤0.01% | 2406 |
|
|
2022
Q3 | $238K | Buy |
+1,800
| New | +$274K | ﹤0.01% | 3394 |
|
|
2022
Q2 | – | Sell |
-7,000
| Closed | -$1.1M | – | 5120 |
|
|
2022
Q1 | $1.1M | Sell |
7,000
-4,200
| -38% | -$609K | ﹤0.01% | 2346 |
|
|
2021
Q4 | $1.44M | Sell |
11,200
-1,400
| -11% | -$184K | ﹤0.01% | 2219 |
|
|
2021
Q3 | $1.66M | Sell |
12,600
-7,900
| -39% | -$1.19M | ﹤0.01% | 2374 |
|
|
2021
Q2 | $3.67M | Buy |
+20,500
| New | +$3.55M | 0.01% | 1413 |
|
|
2021
Q1 | – | Sell |
-2,300
| Closed | -$378K | – | 6145 |
|
|
2020
Q4 | $378K | Sell |
2,300
-10,200
| -82% | -$1.52M | ﹤0.01% | 3485 |
|
|
2020
Q3 | $1.75M | Sell |
12,500
-700
| -5% | -$86.8K | ﹤0.01% | 1585 |
|
|
2020
Q2 | $1.45M | Sell |
13,200
-13,200
| -50% | -$1.46M | ﹤0.01% | 1659 |
|
|
2020
Q1 | $2.63M | Buy |
+26,400
| New | +$3.41M | 0.01% | 1137 |
|
|
2019
Q2 | – | Sell |
-23,600
| Closed | -$3.37M | – | 4790 |
|
|
2019
Q1 | $3.37M | Buy |
23,600
+16,700
| +242% | +$2.18M | 0.01% | 1132 |
|
|
2018
Q4 | $840K | Sell |
6,900
-11,900
| -63% | -$1.77M | ﹤0.01% | 2128 |
|
|
2018
Q3 | $3.16M | Buy |
18,800
+7,200
| +62% | +$1.24M | 0.01% | 1286 |
|
|
2018
Q2 | $1.75M | Hold |
11,600
| – | – | ﹤0.01% | 1710 |
|
|
2018
Q1 | $1.75M | Buy |
11,600
+5,300
| +84% | +$777K | ﹤0.01% | 1710 |
|
|
2017
Q4 | $848K | Sell |
6,300
-3,900
| -38% | -$541K | ﹤0.01% | 2406 |
|
|
2017
Q3 | $1.49M | Sell |
10,200
-4,400
| -30% | -$665K | 0.01% | 1549 |
|
|
2017
Q2 | $2.27M | Sell |
14,600
-1,600
| -10% | -$245K | 0.01% | 1159 |
|
|
2017
Q1 | $2.36M | Sell |
16,200
-12,900
| -44% | -$1.68M | 0.01% | 1073 |
|
|
2016
Q4 | $3.17M | Buy |
+29,100
| New | +$3.24M | 0.02% | 1026 |
|
|
2016
Q3 | – | Sell |
-22,600
| Closed | -$3.18M | – | 4824 |
|
|
2016
Q2 | $3.18M | Buy |
+22,600
| New | +$3.33M | 0.02% | 839 |
|
Other funds holding JAZZ
EC
Wolverine Trading's JAZZ Position: Q1 2025 in Review
Wolverine Trading sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2025, closing a stake of 8,988 shares — an estimated $1.11M sold.
Wolverine Trading first reported a position in JAZZ in Q1 2017 and held it in 13 quarters. The position peaked at $1.89M in Q2 2021. 550 funds tracked by Wall St. Rank hold JAZZ as of Q1 2025.
- Wolverine Trading reported no remaining Jazz Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
- Wolverine Trading sold 8,988 Jazz Pharmaceuticals shares in Q1 2025, an estimated $1.11M.
- Wolverine Trading first reported a position in Jazz Pharmaceuticals in Q1 2017 and held it in 13 quarters.
- Wolverine Trading's Jazz Pharmaceuticals position peaked at $1.89M in Q2 2021.
- 550 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2025.
Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.